Bioelectrix
Gothenburg, SE · 1 known investors
Find your way into Bioelectrix
Bioelectrix develops a novel electrical stimulation technology to accelerate wound healing by delivering stable, controlled electrical signals to tissue. The company targets diabetic foot ulcers and other chronic wounds, with initial focus on patients for whom small wounds can become life-threatening complications.
Founders & leadership
DJ
Dr. José LealCTO & Co-founder
CJ
Caroline JohanseninCEO & Co-founderCaroline Johansen is CEO and co-founder of Bioelectrix, which she joined in 2024, where she works on advancing the company's wound electrodes toward regulatory approval. Bioelectrix develops electrical stimulation technology to accelerate wound healing while monitoring progress and providing data to clinicians and patients.
PM
Prof. Maria AsplundLead Scientific Advisor & Co-founder
Investors · 1
Frequently asked questions
- What does Bioelectrix do?
- Bioelectrix develops a novel electrical stimulation technology to accelerate wound healing by delivering stable, controlled electrical signals to tissue. The company targets diabetic foot ulcers and other chronic wounds, with initial focus on patients for whom small wounds can become life-threatening complications.
- Who founded Bioelectrix?
- Bioelectrix was founded by Dr. José Leal, Caroline Johansen, Prof. Maria Asplund.
- Who are Bioelectrix's investors?
- Bioelectrix's investors include Chalmers Ventures AB.
- Where is Bioelectrix headquartered?
- Bioelectrix is headquartered in Gothenburg, SE.